XPAN secures FDA 510(k) clearance and announces successful completion of initial human clinical cases in the U.S.

Xpan Inc., a medical device company focused on minimally invasive surgical innovation, secured FDA 510(k) clearance on the XpanTM Universal Trocar System – a device that can be tailored by surgeons during laparoscopic procedure, reducing complications and improving quality of care for patients.

XPAN is an OBIO® member, an alumnus of our BDSP™, CAAP®, H2BB™ and HealthMINT™ programs and presented at the OBIO® Investment Summit.